Redcliffe Lifetech was last valued at $150M. The company is private, so there is no listed share price.
One company valuation: $150M.
The closest healthcare peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Redcliffe Lifetech is a private company; its shares do not trade on a public exchange.
The last valuation is $150M.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
